Jing Zheng, Jianya Zhou, Yufang W, Jiahe Shi. "Practical prognostic tool for personalising first-line alectinib in ALK-positive NSCLC: A real-world model integrating neutrophil-to-lymphocyte ratio, lactate dehydrogenase, and eosinophil count.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e20743